The product is the generic version of Mucinex 600mg tablets.
The company intends to begin its full-scale over-the-counter launch of product in blister packaging to its retail and wholesale customers in store brand or own label before the end of its current fiscal year.
Mucinex 600mg tablets are an indicated to relieve chest congestion and make coughs more productive, the company said.
Perrigo chairman and CEO Joseph Papa said: "This is another great new product launch for our team and is representative of Perrigo’s unwavering commitment to make significant investments necessary to bring complex new products to market."